A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines

References

Page 1

	Year	Citations
Treatment of Glabellar Frown Lines with C. Botulinum‐A Exotoxin Jean Carruthers The Journal of Dermatologic Surgery and Oncology	1992	613
Botulinum Toxin Type A as a Migraine Preventive Treatment Stephen D. Silberstein, Ninan T. Mathew, Joel R. Saper, Headache The Journal of Head and Face Pain	2000	540
Pharmacologic weakening of extraocular muscles. Alan B. Scott, Arthur L. Rosenbaum, Carter C. Collins PubMed Extraocular MusclesMuscle PhysiologyMuscle FunctionKinesiologyMuscle Injury	1973	484
Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open‐label study William J. Binder, Mitchell F. Brin, Andrew Blitzer, Otolaryngology	2000	328
A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm Mauro Porta Pain	2000	301
Focal Hyperhidrosis Markus Naumann, U. Hofmann, Ilka Bergmann, Archives of Dermatology	1998	242
Botulinum Toxin for the Treatment of Hyperfunctional Lines of the Face Andrew Blitzer, Mitchell F. Brin, M. Keen, Archives of Otolaryngology - Head and Neck Surgery	1993	240
Botulinum Toxin A for Hyperkinetic Facial Lines: Results of a Double-Blind, Placebo-Controlled Study Monte S. Keen, Andrew Blitzer, Jonathan E. Aviv, Plastic & Reconstructive Surgery OphthalmologyFacial PlasticHyperkinetic Facial LinesBotulinum Toxin AEleven Healthy Subjects	1994	218
Cosmetic Denervation of the Muscles of Facial Expression with Botulinum Toxin A Dose-Response Study Alicia García, James E. Fulton Dermatologic Surgery	1996	203
Therapy with Botulinum Toxin John L. Keltner American Journal of Ophthalmology MedicineToxinologyBotulinum ToxinInnovative Treatment	1995	198

Page 1